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Author: Elena Sánchez-López Alberto Marcos Emilio








Please cite this article as: Elena Sánchez-López, Alberto Marcos, Emilio
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 A CE-ESI-MS2 method is developed to determine Phe-Tyr metabolic pathway 
enantiomers 
 First simultaneous enantioseparation of the constituents of this metabolic 
pathway. 
 First MS detection of the CE enantioseparation of norepinephrine and 
epinephrine. 
 Large volume sample stacking enabled to obtain LODs from 40 to 150 nM. 
 Plasma samples were analyzed and L-Phe and L-Tyr were determined at µM level. 
Abstract 
Catecholamines dopamine, norepinephrine, and epinephrine are well-known 
neurotransmitters playing different roles in the nervous and endocrine system. These 
compounds are biologically synthesized in the phenylalanine-tyrosine pathway which 
consists on the successive conversion of L-phenylalanine into L-tyrosine, L-3,4-
dihydroxyphenylalanine (L-DOPA), dopamine, norepinephrine, and epinephrine. This 
work describes the development of an enantioselective CE-ESI-MS2 methodology 
enabling, for the first time, the simultaneous enantioseparation of all the constituents 
involved in the Phe-Tyr metabolic pathway, since all these compounds except dopamine 
are chiral. The developed method was based on the use of a dual CDs system formed by 
180 mM of methyl-β-CD and 40 mM of 2-hydroxypropyl-β-CD dissolved in 2 M formic 
acid (pH 1.2) and presented the advantage of avoiding the use of any time-consuming 
labelling procedure. LODs ranged from 40 to 150 nM and the unequivocal identification 
of the compounds investigated was achieved through their MS2 spectra. The applicability 





Abbreviations: CMT: counter migration technique; DA: dopamine; DOPA: 3,4-
dihydroxyphenylalanine; EMO: enantiomer migration order; EP: epinephrine; HP-β-
CD: (2-hydroxypropyl)-β-cyclodextrin; LVSS: large volume sample stacking; M-β-CD: 
methyl-β-cyclodextrin; NE: norepinephrine; PFT: partial filling technique.  
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1. Introduction 
The determination of neurotransmitters is an important tool to increase the 
knowledge of neurological processes. The catecholamines dopamine (DA), 
norepinephrine (NE), and epinephrine (EP) are well-known neurotransmitters playing 
important roles in many biological processes and which can also act as hormones in 
stressful situations [1]. Quantification of catecholamines in biological fluids is an 
interesting tool in the diagnosis of several disorders such as schizophrenia, Parkinson’s 
disease or pheochromocytoma [2,3]. These catecholamines are biologically synthesized 
in the Phe-Tyr metabolic pathway (Figure 1). A known pathology related to this 
metabolic pathway is phenylketonuria, an inborn error of metabolism which results in 
large excess of Phe in blood and urine [4], what can derive in mental retardation as a 
consequence of low level of Tyr and catecholamines [5]. Previous works also 
demonstrated the relationship between some mental disorders and the availability of 
precursors of catecholamines in cerebrospinal fluid of monkeys [6]. Likewise, the 
reduction of 3,4-dihydroxyphenylalanine (DOPA) synthesis by using the alpha-methyl-
p-tyrosine inhibitor also results in a transient decrease in catecholamine synthesis [7]. 
4 
 
All the compounds involved in the Phe-Tyr metabolic pathway (see Figure 1) 
except DA are chiral, therefore it is of high interest to study their stereochemistry, 
especially since only the L-enantiomers of the involved amino acids can lead to these 
important neuroactive molecules. Thus, D-Phe and D-Tyr were found to be present in 
different physiological fluids such as plasma, urine, cerebrospinal fluid, and amniotic 
fluid [8]. Moreover, it has been shown that D-Tyr has deleterious effects inhibiting the 
growth of mice [9]. On the other hand, Parkinson’s disease therapy includes 
administration of the L-form of DOPA in order to replenish DA, whereas that D-DOPA 
not only cannot be converted to DA but also presents side effects [10, 11]. 
The study of the chirality of biological molecules acquires great importance since, 
although in the past it was assumed that only L-amino acids were the natural existing 
form [12], later studies demonstrated that the D-forms were also present in some micro-
organisms [13], in amphibians and invertebrates and even in mammals, including humans 
[14] either as a result of spontaneous racemization of L-forms in the structure of 
polypeptides when ageing [15,16] or as endogenous substances [17-19]. The amino acid 
D-Serine is an example of this, as it is an important neuroactive molecule whose levels in 
mammals can even exceed the concentration of many L-amino acids [20]. Thereby, it is 
of high importance to increase the knowledge of the activity of enantiomers, whose 
determination still remains as a promising topic in the analytical sciences field. 
Due to the fact that a pair of enantiomers presents the same physicochemical 
properties with the exception of opposite optical rotation of plane-polarized light and 
differential strength of the interactions with chiral compounds, their separation is a 
challenging task that could require the MS in order to achieve the necessary sensitivity 
and the unequivocal detection of the investigated compounds when these are in complex 
samples. Regarding the Phe-Tyr metabolic pathway, GC, LC, and CE have been the 
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separation techniques employed to achieve the enantiomeric separations of its individual 
components or partial mixtures of them using different detection systems. Thus, the 
enantiomeric determination of Phe and Tyr, generally in mixtures with more 
proteinogenic amino acids, has been reported in numerous articles but their determination 
in biological fluids has been less frequent. Over the last 20 years, some of these works 
include the use of GC-MS employing Chirasil-L-Val as stationary phase [21,22], LC-MS 
employing either cinchona alkaloid based chiral stationary phases [23, 24] or a chiral 
derivatization reagent [25-27], CE-UV with a chiral labelling agent [28], CE-LIF with a 
chiral derivatization reagent [29] or cyclodextrins [30,31] and CE-MS employing a chiral 
crown ether [32]. Note that all these methodologies required time-consuming 
derivatization steps except the last one [32]. Regarding the other chiral constituents of the 
Phe-Tyr metabolic pathway, DOPA, NE and EP, a considerable minor number of articles 
reporting their enantiomeric separation have been published. In the last 20 years, 
enantioseparation of DOPA, NE, or EP has not been reported by GC. In the case of LC, 
none described the enantioseparation of DOPA, while the individual or simultaneous 
enantioseparation of NE and EP was reported only in two works [27, 33]. Concerning 
CE, some articles have been published dealing with the enantiomeric separation of DOPA 
[34-40], as well as mixtures of DOPA with Phe and Tyr using MS detection [41], or even 
the enantiomeric separation although not simultaneously of DOPA, and other components 
of the Phe-Tyr metabolic pathway using UV detection [42]. Regarding the simultaneous 
enantioseparation of NE and EP by CE, some studies have been described using UV [1, 
43-47] or electrochemical detection [48], but these compounds have never been 
enantioseparated using a CE-MS system.  
In summary, to the best of our knowledge, the constituents of the Phe-Tyr 
metabolic pathway have never been simultaneously enantioseparated. Only an old 
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method published in 1996 [42] described the separation within 60 min of these 
compounds using sulfated-β-CD as chiral selector in CE-UV but, the simultaneous 
separation was not possible due to the overlapping of DA, and NE and EP enantiomers. 
In addition, this methodology is not compatible with MS detection under the conditions 
assayed. Thus, it is of special interest to develop a methodology enabling the simultaneous 
enantioseparation and unequivocal detection of the compounds involved in the Phe-Tyr 
metabolic pathway in a single run, without the need of using time-consuming 
derivatization steps. 
Since CE offers numerous advantages for chiral analysis such as high separation 
efficiency, excellent enantioselectivity and low reagents and solvents consumption 
(including chiral selectors), what makes it an environmental-friendly technique [49-52], 
this technique was employed in this work with the aim of developing an enantioselective 
CE-ESI-MS2 methodology to carry out, for the first time, the simultaneous 
enantioseparation and unequivocal detection of all the Phe-Tyr metabolic pathway 
constituents avoiding the use of any derivatization procedure. Firstly, investigation on the 
enantiodiscrimination of several chiral selectors towards these compounds is presented in 
CE-UV. Secondly, the methodology is implemented in a MS system and, after testing its 
analytical characteristics, it is applied to the analysis of rat plasma. We consider that 
testing our enantioselective CE-ESI-MS2 methodology to separate and detect all the Phe-
Tyr metabolic pathway constituents in biological samples such as rat plasma could be 







2. Materials and methods 
2.1. Reagents 
All reagents were of analytical grade. MS-grade acetonitrile and methanol were 
obtained from Scharlau Chemie (Barcelona, Spain) while formic acid, perchloric acid, 
ammonium carbonate, ammonium hydroxide, and EDTA were from Sigma (St. Louis, 
MO, USA). Ammonium acetate was from Merck (Darmstadt, Germany), ascorbic acid 
was obtained from VWR (Radnor, PA, USA) and isoflurane from Abbott (Madrid, 
Spain). The employed water was MilliQ quality (Millipore, Bedford, MA, USA). β-CD, 
sulfated-β-CD (degree of substitution (DS): 12-14), methyl-β-CD (M--CD) (DS 1.7-
1.9), 2-hydroxypropyl-β-CD (HP-β-CD) (DS~4.2), 2,6-di-O-methyl-β-CD (DM-β-CD), 
and carboxymethyl-β-CD (CM-β-CD) (DS~3) were purchased from Fluka (Switzerland). 
Acetyl-β-CD (A-β-CD)(DS 7), γ-CD, methyl-γ-CD (M-γ-CD) (DS~12), 2-
hydroxypropyl-γ-CD (HP-γ-CD) (DS~4.5), HP-γ-CD (DS~3.2), carboxyethylated-β-CD 
(CE-β-CD) (DS ~3), carboxymethylated-γ-CD (CM-γ-CD) (DS ~3), and 
carboxyethylated-γ-CD (CE-γ-CD) (DS ~3) were purchased from Cyclolab (Hungary). 
DL-Phe and DL-EP were from Aldrich (St. Louis, MO, USA), L-Phe, D-Tyr, L-Tyr, and 
DL-NE in Fluka (Buchs, Switzerland) and DL-DOPA, L-DOPA, L-NE, L-EP, DA, and 
trigonelline hydrochloride in Sigma (St. Louis, MO, USA). 
 
2.2. CE-UV conditions 
 Electrophoretic experiments were carried out on a HP3DCE system from Agilent 
Technologies (Palo Alto, USA) with a diode array detector. The electrophoretic system, 
and the data collection were controlled by HP3DCE ChemStation software. The BGE 
employed consisted of a dual CDs system based on 100 mM M-β-CD and 60 mM HP-β-
CD dissolved in 2 M formic acid (pH 1.2). Separations were performed in an uncoated 
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fused-silica capillary of 50 µm I.D. and a total length of 88.5 cm, purchased from 
Polymicro Technologies (Phoenix, USA) at +30 kV and 15 ºC. Injections were carried 
out applying 5000 Pa (50 mbar) for 5 s. Detector parameters were a wavelength of 200 ± 
5 nm. At the beginning of the day the capillary was flushed with buffer solution for 10 
min and at the end of the day with MilliQ-water for 5 min. In order to ensure the 
repeatability between injections, the capillary was flushed with buffer solution for 2 min 
and BGE for 5 min. 
 
2.3. CE-ESI-MS2 conditions 
CE-MS analyses were performed in a HP3DCE instrument (Agilent Technologies, 
Palo Alto, USA) coupled through an orthogonal coaxial sheath interface (model G1607A 
from Agilent Technologies, Palo Alto, USA) to the Electrospray Ionization (ESI) source 
of an Ion Trap mass spectrometer (model AmaZon SL from Bruker Daltonics, Germany) 
for MS detection. For MS control and data analysis, TrapControl Software 7.0 for 
AmaZon was used. BGE employed was 2 M formic acid (pH 1.2). The separation was 
achieved in an uncoated fused-silica capillary of 120 cm and 50 µm I.D., at +30 kV and 
15 ºC. Injections were performed applying 5000 Pa (50 mbar) for 250 s. Between analysis, 
the capillary was flushed applying 100000 Pa (1 bar) with BGE for 4 min, and a mixture 
of 180 mM M-β-CD and 40 mM HP-β-CD dissolved in 2 M formic acid (pH 1.2) for 2.5 
min. 
MS conditions were a 50:50 (v/v) methanol/water with 0.1 % (v/v) formic acid 
sheath liquid at 3.3 µL/min by a 2.5 mL syringe pump (Hamilton, USA). The nebulizer 
and drying gas (N2) were 20684 Pa (3 psi) and 5 L/min at 200 ºC. The mass spectrometer 
operated with the ESI source in the positive ion mode at -4.5 kV with an end plate of -
500 V. The ion optical parameters were tuned in the “expert mode”. In MS2 experiments 
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the Ion Charge Control (ICC) was activated with a target up to 100,000 ions using 200 
ms of accumulation time and 1 average. The m/z scanned range was from 100 to 210 m/z 
in the “Enhanced Resolution” mode (8,100 (m/z)/s). MS2 experiments were accomplished 
by the fragmentation of the precursor ions of the six compounds (m/z 154.0, 152.0, 184.0, 
198.0, 165.9 and 181.9 for DA, NE, EP, DOPA, Phe, and Tyr, respectively) and the 
internal standard (IS) trigonelline (m/z 138.0) by means of the pseudo-multiple reaction 
monitoring mode. The isolation width of each precursor ion was set to 2.0 m/z where its 
fragmentation was carried out by collision-induced dissociation with the helium present 
in the trap. Extracted Ion Electropherograms were obtained extracting the corresponding 
product ions with an extraction window of -0.3/+0.7 m/z using a smoothed option of the 
software (Gauss at 1 point). 
 
2.4. Animal sampling  
Male Wistar rats (Barcelona, Spain) weighting 300-330 g were housed at a 
constant temperature (20 ± 2 °C) on a 12-hour light/dark cycle (lights on at 08:00 hours), 
with ad libitum access to food and water. Animals were maintained and handled 
according to European Union guidelines for the care of laboratory animals (Directive 
2010/63/EU) and the “Principles of laboratory animal care” were followed. All 
procedures were approved by the bioethics committee of the Universidad Nacional de 
Educación a Distancia (Madrid, Spain). 
Rats were anesthetized with isoflurane, decapitated and blood was recollected in 
heparinized tubes, centrifuged for 10 min at 2000xg (4 ºC) and plasma was collected and 





2.5. Preparation of samples  
Rat plasma samples were treated with acetonitrile to precipitate proteins 
(plasma:acetonitrile, 1:2), then centrifuged at 10000xg for 15 min at 4 ºC and, the 
supernatant was diluted with formic acid (1:1) so that its final concentration is 0.25 M. 
All samples contained a final concentration of the IS trigonelline of 20 µM. All solutions 
were sonicated and filtered with 0.2 µm polytetrafluorethylene filters prior CE analysis. 
 
3. Results and discussion 
 
3.1. Investigation on the chiral separation of the constituents of the Phe-Tyr metabolic 
pathway by CE 
In order to develop a chiral methodology enabling the enantioseparation of all the 
constituents involved in the Phe-Tyr metabolic pathway, the enantiodiscrimination power 
of different chiral selectors towards these compounds was investigated using CE-UV. 
First, counter migration technique (CMT) was evaluated aiming to avoid the undesired 
presence of the chiral selector in the detection system making the future MS-coupling 
easier. Thus, negative sulfated-β-CD was employed due to its contrary migration to that 
of the studied analytes. Enantioselectivity of sulfated-β-CD was tested at concentrations 
ranging from 0.2 to 0.6 mM in 200 mM ammonium formate buffer (pH 3.0) and the 
separation was performed in 88.5 cm fused-silica capillary of 50 µm I.D., at 30 kV and 
15 ºC. In the tested CD concentration range, enantioseparation for amino acids Phe, Tyr 
and DOPA was accomplished, however, catecholamines DA, NE and EP could not be 
detected, due to their extremely high interaction with the anionic CD which migrates 
away from the detector in normal polarity. In order to detect the catecholamines, the EOF 
was raised increasing the pH to 5.0 and to 7.0, but although the enantioseparation of NE 
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and EP was achieved under the new tested conditions, amino acids Phe, Tyr and DOPA 
could not be enantioresolved. 
Since it was not possible to enantioseparate all the studied compounds with the 
CMT approach under the same conditions, the next strategy was to carry out a screening 
with several neutral CDs dissolved in an extremely acid media (2 M formic acid (pH 
1.2)). With this BGE all studied compounds are under the same ionic net charge (pKa 
values shown in Figure 1) and the EOF is totally suppressed so that these positively 
charged analytes can migrate faster than the CD. These are ideal conditions for 
developing a partial filling technique (PFT), strategy required when using the method in 
MS. 
Eight β-CDs (β-CD, A-β-CD, DM-β-CD, M-β-CD, HP-β-CD, CE-β-CD, CM-β-
CD, succ-β-CD) and five γ-CDs (γ-CD, M-γ-CD, HP-γ-CD, CE-γ-CD, and CM-γ-CD) 
were tested at concentrations ranging from 5 to 80 mM except β-CD which was studied 
from 1 to 12 mM due to its low aqueous-solubility. Concerning γ-CD derivatives only 80 
mM of M-γ-CD allowed enantiodiscrimination of Tyr and DOPA (Rs 1.5 and 2.6, 
respectively) but did not offer enantioselectivity for Phe, NE, or EP. Regarding β-CD 
derivatives, all of them except the native β-CD allowed baseline enantioseparation for NE 
and EP, however, just succ-β-CD, M-β-CD, and HP-β-CD also enabled 
enantiodiscrimination for some of the studied amino acids where Rs increased as the 
concentration increased. Thereby, 80 mM of succ-β-CD could not discriminate Tyr 
enantiomers but offered partial enantioseparation for Phe (Rs 0.6) and DOPA (Rs 1.3). 
Additionally, DOPA enantiomer migration order (EMO) enabled the minor enantiomer 
to be the last one to migrate making it hard to be detected when large amounts of L-
enantiomer are present. Unlike succ-β-CD, 80 mM of M-β-CD offered enantioseparation 
for Tyr (Rs 1.5) besides partial enantioseparation for Phe (Rs 1.0) and peak broadening 
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for DOPA. M-β-CD allowed the D-amino acids to migrate in first place whereas that in 
the case of the catecholamines L-enantiomers migrated first, however since Rs was high 
enough it was possible to detect D-enantiomers in presence of high amounts of L-
enantiomers. The difference in the EMO might be justified by the different position of 
the chiral center (in the carbon-β for amino acids and in the carbon-α for catecholamines), 
thus modifying their enantiorecognition. On the other hand, 80 mM of HP-β-CD offered 
enantiodiscrimination for Phe and DOPA but peak broadening was observed for Tyr, and 
the EMO was the same as with M-β-CD. 
Therefore, M-β-CD could be a potent chiral selector to carry out the 
enantioseparation of the studied compounds. In order to enhance the Rs its concentration 
was studied in a range from 80 to 180 mM where 160 mM originated the best Rs and 
allowed the individual enantioseparation of all the compounds including DOPA (Rs 
ranging from 1.5 to 6.0), although simultaneous enantioseparation could not be achieved 
due to the co-migration of DOPA enantiomers with Phe enantiomers (Figure 2). On the 
other hand, the optimum concentration for HP-β-CD, the CD which also offered good Rs 
and presented the same EMO as M-β-CD, was investigated being 160 mM also the 
optimum concentration. As can be seen in Figure 2, 160 mM of HP-β-CD avoided the 
co-migration of enantiomers of Phe and DOPA but the Rs obtained with this CD was 
worse than the one obtained with M-β-CD. It seems that M-β-CD is the CD which most 
influences the Rs of each analyte whereas that HP-β-CD affects the simultaneous 
separation of the analytes of interest thus, the use of a dual CDs system consisting of a 
mixture of M-β-CD and HP-β-CD was evaluated as they showed to offer combined 
effects. Different combinations were tested being 100 mM of M-β-CD with 60 mM of 
HP-β-CD the mixture which presented the best Rs for the simultaneous enantioseparation 
in the shortest analysis time. Finally, the effect of the separation temperature was 
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evaluated from 15 to 35 ºC, being 15 ºC the optimum in terms of Rs. It is important to 
highlight that, not only the enantioseparation of these compounds, but also their 
individual separation was a very challenging task since the chemical structure of the 
studied compounds is very similar, as they belong to the same metabolic pathway (they 
are just differentiated by gains or losses of small molecules such as OH, CH2 or HCO2). 
The enantioseparation of all components of the Phe-Tyr metabolic pathway under the 
optimal conditions is shown in Figure 3. 
 
3.2. Optimization of the CE-ESI-MS2 methodology 
 Once the chiral methodology was developed in an UV detection system, the next 
step consisted on transferring the method to a MS system in order to increase the 
sensitivity and selectivity. To avoid the undesired entry of the chiral selector in the 
detection system and to enhance the sensitivity, the possibility of using a PFT was studied 
since, as described above, it was not possible to develop a CMT. Thus, the employed 
capillary (88.5 cm length) was 70 % filled with the CD mixture by applying 100000 Pa 
(1 bar) for 1.6 min. Under these conditions, analytes migrated faster than in CE-UV as a 
consequence of the suction effect produced in the MS system and also as a result of the 
higher apparent mobility of analytes due to the reduced chiral selector band in the 
capillary, detecting the studied analytes with analysis times around 30 min with a 
remarkable loss in the Rs. In order to obtain a good enantioresolution in the shortest 
possible analysis time, the capillary length and the time to fill the chiral selector band 
were optimized. 120 cm and 2.5 min (i.e. a 83 % of the capillary was filled with the CDs 
mixture) were the best in terms of Rs, analytes migration times, and time distance between 
the last analyte (L-Tyr) and the band of CDs. Since the enantioresolution was not good 
enough, a re-optimization of the concentration of CDs mixture employed in the PFT was 
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necessary, and several combinations of the mixture of CDs were tested. Although none 
of the tested combinations offered baseline Rs for DOPA enantiomers, with 180 mM for 
M-β-CD and 40 mM for HP-β-CD, complete individual and simultaneous 
enantioseparation were obtained for the rest of compounds. It is important to highlight 
that the sensitivity increased up to 3 times when using PFT over complete filling of the 
capillary with the mixture of CDs as it generated ion suppression caused by its entry in 
the MS system. 
After re-optimizing the CE separation conditions, MS parameters were optimized. 
It was observed that high amounts of methanol (80 %) in the sheath liquid (SL), required 
to obtain a stable formation of ions in the ESI interface between CE and MS, generated 
instability in the ionic current of the MS system, so a mixture composed of 
methanol:water (50:50 (v/v)) with formic acid 0.1 % (v/v) was chosen. Among all studied 
flow rates of SL, 3.3 µL/min offered good sensitivity and a stable ionic current in the MS 
system. Likewise, different ESI parameters were adjusted aiming to obtain the best 
sensitivity in terms of S/N. Thus, the optimum applied voltage was 4500 V as it offered 
the best S/N and a stable ionic current. Optimal values for nebulizer pressure and drying 
gas flow were 20684 Pa (3 psi) and 5 L/min, respectively. Finally, 200 ºC for drying gas 
temperature was the optimum value to achieve the best S/N. 
Before optimizing the trap parameters, the first optical parameter to be optimized 
was the capillary exit voltage present in the first vacuum stage (zone of collision induced 
fragmentation of the formed in the ESI before going into the analyzer) to avoid 
fragmentation of quasi-molecular ions ([M+H]+). 60 V was selected to obtain the 
protonated molecular ions of each compound (except NE) as the base peak of the MS 
spectra, so they were chosen as precursor ions for MS2 experiment. In the case of NE two 
ions were majority, being the ion at m/z 152.0 (resulting from the loss of a water molecule 
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[M-H2O+H]+) its base peak, more abundant than the ion [M+H]+, so it was selected as the 
precursor ion for NE in the MS2 experiment. Table 1 shows the values for other optimized 
MS2 parameters and Figure 4A shows the separation obtained. 
Finally, in order to increase the method sensitivity, sample pre-concentration by 
means of an injection with large volume sample stacking (LVSS) was considered. 
Different injection times were tested being 250 s the one which presented the best 
sensitivity without harming the Rs and the peak shape (see Figure 4B). This 
preconcentration strategy enabled to improve sensitivity about 50 times when compared 
to the 5 s standard injection. 
 
3.3. Analytical characteristics of the CE-ESI-MS2 methodology and application to the 
analysis of rat plasma samples 
With the aim of applying the developed CE-ESI-MS2 methodology to the analysis 
of plasma samples, the analytical characteristics of the method were evaluated in terms 
of selectivity, linearity, accuracy, precision, and sensitivity for DA, L-NE, L-EP, L-
DOPA, L-Phe, and L-Tyr in rat plasma. 
The fact that the plasma samples were treated with acetonitrile to carry out the 
protein precipitation affected negatively the separation due to a decrease in the 
conductivity of the medium. This led to peak broadening and longer analysis times. To 
overcome this issue a sample dilution was considered, establishing the need to perform a 
1:1 dilution of the treated sample with formic acid 0.25 M prior to injection into the CE 
system. 
Figure 5 demonstrates the good selectivity of the developed methodology; on the 
one hand there is complete resolution within the individual compounds including their 
enantiomers (baseline for all of them except for DOPA), on the other hand all analytes 
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have different m/z values and could be identified by their MS2 spectra. Initially, it could 
be thought that the complete resolution within the individual compounds is not even 
required as they can be distinguished by MS. However, the differences between the 
compounds of interest in some cases are very small (only two units of m/z, which could 
involve errors in the isolated precursor ions due to the presence of isotope ions of other 
compounds) and other times these may differ with regard to the functional groups 
differences may be due to very likely lost as are the groups OH, H2O, or COOH HCO2. 
Also, something important to take into account is the ion suppression, which might be 
caused if several analytes co-elute. Therefore, on certain occasions it is desirable to have 
individual separation of the studied compounds, especially when the chemical structure 
of the compounds is very similar. Likewise, an adequate selectivity was achieved as no 
interfering peaks were observed when a plasma sample was analyzed (see Figure 6A). 
This is of extreme importance since in biological samples it is common to find molecules 
with same monoisotopic mass, and therefore can interfere in the proper determination 
and/or quantification of a certain compound. 
The results of the rest of analytical characteristics are shown in Table 2. 
Quantification of the analytes of interest was carried out by means of the internal standard 
calibration method. The IS selected was trigonelline since its chemical structure was 
similar to the studied compounds, it was not present in the matrix sample, and it migrated 
at 60 min, near the analytes without interfering (Figure 6). Good linearity was achieved 
for all compounds (R2 > 99 %), when plotting the corrected peak areas of each analyte 
divided by the corrected peak area of the IS versus the concentration of each analyte 
divided by concentration of the IS. Confidence interval for the slope did not include the 
zero value and confidence interval for the intercept included the zero value in all cases 
(confidence level of 95 %). It was found that there were not matrix interferences since 
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there were not significant differences between the slopes obtained by the internal standard 
and the standard additions calibration methods (P-values > 0.05, for a confidence level of 
95 %). On the other hand, good recovery values were obtained, ranging from 87 to 105 
% with precision values from 7 to 15 %. Instrumental and method repeatability, and 
intermediate precision were adequate, as RSD % values ranged from 1.8 to 3.3 % in the 
case of migration times and from 9.2 to 16.9 % for corrected peak areas. Regarding the 
method sensitivity, the LODs ranged from 40 to 150 nM and the LOQs from 133 to 500 
nM. Although the migration times increased and Rs decreased when compared to the CE-
UV method, the CE-ESI-MS2 methodology enabled to improve the LODs from 200 (in 
the case of NE) to 3500 times (for DA). 
Figure 6 shows the electropherograms corresponding to a rat plasma sample and 
the same sample spiked with the analytes of interest. The compounds found in the 
analyzed samples were L-Phe and L-Tyr, being the contents of the other compounds 
below their respective LODs. The fact that Catecholamines and DOPA could not be 
detected in our plasma samples since their physiological levels in healthy subjects, 0.5, 
1.6, and 8.5 nM for EP, NE, and DOPA [53], respectively, are much lower than the herein 
reported LOD (40, 150, and 54 nM for EP, NE, and DOPA, respectively). is due to could 
be because we analyzed healthy subjects, and their concentration were below the LOD of 
the proposed methodology. Slightly higher levels of these compounds have been found 
in diseased samples (1.0, 3.7, and 10.9 nM for EP, NE, and DOPA [53], respectively), 
although these values are still below the LOD of our method. Even It has been seen that 
higher levels of catecholamines and DOPA are found in diseased samples when compared 
to healthy subjects, these concentrations being in the nM level for catecholamines [53] 
and have been also reported in diseased samples, in the µM range for DOPA [54]. 
Regarding D-Phe and D-Tyr, they have been reported to be present in a percentage of 0.8 
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and 0.6 %, for D-Phe and D-Tyr, respectively, referred to their corresponding L-forms 
[8]. The fact that the percentage that our method allows to detect is 2.3 and 2.2 % for D-
Phe and D-Tyr, respectively, could be the reason why they could not be detected. Further 
improvements in sensitivity using the sheathless interface [55] or preconcentration 
strategies [56] could enable the detection of these analytes. 
In spite of this issue, as can be seen in Figure 6B the studied analytes could be 
determined in spiked plasma samples analyzed by the developed CE-ESI-MS2 method. 
The concentrations of the determined amino acids, quantified by the internal standard 
calibration method and considering the sample treatment were 51 ± 3 µM for L-Phe, and 
55 ± 3 µM for L-Tyr. These values are in agreement with those reported in the literature 
[57], thus demonstrating the validity of the proposed methodology. 
 
4. Conclusions 
An enantioselective CE-ESI-MS2 methodology has been developed enabling, for 
the first time, the simultaneous enantioseparation of all the constituents of the Phe-Tyr 
metabolic pathway. A thorough study on the chiral recognition obtained for these 
compounds towards different CDs has been carried out showing that the best 
enantioselectivity was obtained with a mixture 180 mM in M-β-CD and 40 mM in HP-β-
CD in an acidic medium (2 M formic acid at pH 1.2).  
The CE-ESI-MS2 methodology developed in this work enabled to obtain LODs 
values ranging from 40 to 150 nM for the constituents of the Phe-Tyr metabolic pathway 
in addition to their simultaneous analysis in a unique run. Moreover, no derivatization 
steps were necessary. This is also the first time that NE and EP enantiomers are separated 
by CE-MS.  
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The developed method was applied demonstrated its applicability to the analysis 
of biological fluids showing that L-Phe and L-Tyr were present in the analyzed rat plasma 
samples analyzed at the µM level. 
 
 
Conflicts of interest 
 Authors declare that they have no conflict of interest 
 
Acknowledgments 
The authors thank the Ministry of Economy and Competitiveness (Spain) for 
research project CTQ2013-48740-P, the University of Alcalá for the research project 
CCG2013/EXP-065 and the Government Delegation for the National Plan on Drugs of 
the Ministry of Health, Social Services and Equality (Spain) for the research project 





5. References  
[1] S. Wei, G. Song, J.M. Lin, Separation and determination of norepinephrine, 
epinephrine, and isoprenaline enantiomers by capillary electrophoresis in pharmaceutical 
formulation and human serum, J. Chromatogr. A 1098 (2005) 166-171. 
[2] R. Adolfsson, C.G. Gottfries, B.E. Roos, B. Winblad, Changes in the brain 
catecholamines in patients with dementia of Alzheimer type, Br. J. Psychiatry 135 (1979) 
216-223. 
[3] L.F. Nolden, T. Tartavoulle, D.J. Porche, Parkinson’s disease: assessment, diagnosis, 
and management, J. Nurse Pract. 10 (2014) 500-506. 
[4] G. Guroff, Effects of inborn errors of metabolism on the nutrition of the brain, in: R.J. 
Wurtmann, J.J. Wurtmann (Eds.) Nutrition and the Brain. New York, Raven Press, 1979, 
pp. 29-68. 
[5] V.L. Brumm, M.L. Grant, The role of intelligence in phenylketonuria: a review of 
research and management, Mol. Genet. Metab. 99 (2010) S18-S21. 
[6] R. M. Palmour, F. R. Ervin, G. B. Baker, S. N. Young, An amino acid mixture 
deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine 
metabolites and alcohol consumption in vervet monkeys, Psychopharmacology 136 
(1998) 1-7. 
[7] L. Booij, A. J. W. van der Does, W. J. Riedel, Monoamine depletion in psychiatric 
and healthy populations: review, Mol. Psychiatr. 8 (2003) 951-973.  
[8] D. W. Armstrong, M. Gasper, S. H. Lee, J. Zukowski, N. Ercal, D-amino acid levels 
in human physiological fluids, Chirality 5 (1993) 375-378 
[9] M. Friedman, Chemistry, nutrition, and microbiology of D-amino acids, J. Agric. 
Food Chem. 47 (1999) 3457-3479. 
21 
 
[10] J. Wang, Y. Fang, Determination, purity assessment, and chiral separation of 
levodopa methyl ester in bulk and formulation pharmaceuticals, Biomed. Chromatogr. 20 
(2006) 904-910. 
[11] M. Blanco, I. Valverde, Chiral and non-chiral determination of DOPA by capillary 
electrophoresis, J. Pharm. Biomed. Anal. 31 (2003) 431-438. 
[12] V.S. Lamzin, Z. Dauter, K.S. Wilson, How nature deals with stereoisomers, Curr. 
Opin. Struct. Biol. 5 (1995) 830-836. 
[13] J.J Corrigan, D-Amino acids in animals, Science 164 (1969) 142-149. 
[14] A. Hashimoto, S. Kumashiro, T. Nishikawa, T. Oka, K. Takahashi, T. Mito, S. 
Takashima, N. Doi, Y. Mizutani, T. Yamazaki, Embryonic development and postnatal 
changes in free D-aspartate and D-serine in the human prefrontal cortex, J. Neurochem. 
61 (1993) 348-351. 
[15] N. Fujii, Y. Kaji, N. Fujii, D-Amino acids in aged proteins: Analysis and biological 
relevance, J. Chromatogr. B 879 (2011) 3141-3147. 
[16] A.V. Chervyakov, N.V. Gulyaeva, M.N. Zakharova, D-amino acids in normal ageing 
and pathogenesis of neurodegenerative diseases, Neurochem. J. 5 (2011) 100-114. 
[17] J. Sasabe, M. Suzuki, Y. Miyoshi, Y. Tojo, C. Okamura, S. Ito, R. Konno, M. Mita, 
K. Hamase, S. Aiso, Ischemic acute kidney injury perturbs homeostasis of serine 
enantiomers in the body fluid in mice: early detection of renal dysfunction using the ratio 
of serine enantiomers, PLoS One 9 (2014) e86504/1-e86504/9. 
[18] S. Karakawa, Y. Miyoshi, R. Konno, S. Koyanagi, M. Mita, S. Ohdo, K. Hamase, 
Two-dimensional high-performance liquid chromatographic determination of day-night 
variation of D-alanine in mammals and factors controlling the circadian, Anal. Bioanal. 
Chem. 405 (2013) 8083-8091. 
22 
 
[19] A. Giuffrida, G. Maccarrone, V. Cucinotta, S. Orlandini, A. Contino, Recent 
advances in chiral separation of amino acids using capillary electromigration techniques, 
J. Chromatogr. A 1363 (2014) 41-50. 
[20] A. Hashimoto, T. Oka, T. Nishikawa, Extracellular concentration of endogenous free 
D-serine in the rat brain as revealed by in vivo microdialysis, Neuroscience 66 (1995) 
635–643. 
[21] H. Brückner, A. Schieber, Determination of amino acid enantiomers in human urine 
and blood serum by gas chromatography-mass spectrometry, Biomed. Chrom. 15 (2001) 
166-172. 
[22] M. P. Lorenzo, D. Dudzik, E. Varas, M. Gibellini, M. Skotnicki, M. Zorawski, W. 
Zarzycki, F. Pellati, A. García, Optimization and validation of a chiral GC-MS method 
for the determination of free D-amino acids ratio in human urine: application to a 
gestational diabetes mellitus study, J. Pharm. Biomed. Anal. 107 (2015) 480-487. 
[23] W. F. Visser, N. M. Verhoeven-Duif, R. Ophoff, S. Bakker, L. W. Klomp, R. Berger, 
T. J. de Koning, A sensitive and simple ultra-high-performance-liquid chromatography-
tandem mass spectrometry based method for the quantification of D-amino acids in body 
fluids, J. Chromatogr. A 1218 (2011) 7130–7136. 
[24] R. J. Reischl, L. Hartmanova, M. Carrozzo, M. Huszar, P. Frühauf, W. Lindner, 
Chemoselective and enantioselective anlaysis of proteinogenic amino acids utilizing N-
derivatization and 1-D enantioselective anion-exchange chromatography in combination 
with tandem mass spectrometric detection, J. Chromatogr. A 1218 (2011) 8379-8387. 
[25] R. Reischl, W. Lindner, Methoxyquinoline labeling-A new strategy for the 
enantioseparation of all chiral proteinogenic amino acids in 1-dimensional liquid 
chromatography using fluorescence and tandem mass spectrometric detection, J. 
Chromatogr. A, 1269 (2012) 262-269. 
23 
 
[26] C. Müller, J. R. Fonseca, T. M. Rock, S. Krauss-Etschmann, P. Schmitt-Kopplin, 
Enantioseparation and selective detection of D-amino acids by ultra-high-performance 
liquid chromatography/mass spectrometry in analysis of complex biological samples, J. 
Chromatogr. A 1324 (2014) 109-114. 
[27] T. Mochizuki, T. Takayama, K. Todoroki, K. Inoue, J. Z. Min, T. Toyo’oka, Towards 
the chiral metabolomics: Liquid chromatography-mass spectrometry based DL-amino 
acid analysis after labeling with a new chiral reagent, (S)-2,5-dioxopyrrolidin-1-yl-1-(4,
6-dimethoxy-1,3,5-triazin-2-yl)pyrrolidine-2-carboxylate, and the application to saliva of 
healthy volunteers, Anal. Chim. Acta 875 (2015) 73–82. 
[28] I. Fradi, E. Farcas, A. B. Said, M. L. Yans, C. Lamalle, G. W. Somsen, A. Prior, G. 
J. de Jong, M. Kallel, J. Crommen, A. C. Servais, M. Fillet, In-capillary derivatization 
with (-)-1-(9-fluorenyl)ethyl chloroformate as chiral labeling agent for the electrophoretic 
separation of amino acids, J. Chromatogr. A, 1363 (2014) 338-347. 
[29] G. Thorsen, J Bergquist, Chiral separation of amino acids in biological fluids by 
micellar electrokinetic chromatography with laser-induced fluorescence detection, J. 
Chromatogr. B 745 (2000) 389-397. 
[30] M. P. Lorenzo, A. Villaseñor, A. Ramamoorthy, A. García, Optimization and 
validation of a capillary electrophoresis laser-induced fluorescence method for amino 
acids determination in human plasma: application to bipolar disorder study, 
Electrophoresis, 34 (2013) 1701-1709. 
[31] Y. Huang, M. Shi, S. Zhao, H. Liang, Trace analysis of D-tyrosine in biological 
samples by microchip electrophoresis with laser induced fluorescence detection, J. 
Chromatogr. B, 879 (2011) 3203-3207. 
24 
 
[32] C. Schultz, M. Moini, Analysis of underivatized amino acids and their D/L-
enantiomers by sheathless capillary electrophoresis/electrospray ionization-mass 
spectrometry, Anal. Chem. 75 (2003) 1508-1513. 
[33] V. P. Rane, K. R. Patil, J. N. Sangshetti, D. B. Shinde, Enantiomeric LC separation 
of epinephrine on amylose based sorbent, Chromatographia 67 (2008) 777-781. 
[34] S. Sarac, B. Chankvetadze, G. Blaschke, Enantioseparation of 3,4-
dihydroxyphenylalanine and 2-hydrazino-2-methyl-3-(3,4-dihydroxyphenyl)propanoic 
acid by capillary electrophoresis using cyclodextrins, J. Chromatogr. A, 875 (2000) 379–
3870. 
[35] J. Shen, S. Zhao, Enantiomeric separation of naphthalene-2,3-dicarboxaldehyde 
derivatized DL-3,4-dihydroxyphenylalanine and optical purity analysis of L-3,4-
dihydroxyphenylalanine drug by cyclodextrin-modified micellar electrokinetic 
chromatography, J. Chromatogr. A, 1059 (2004) 209–214. 
[36] M. Dolezalova, S. Fanali, Enantiomeric separation of dihydroxyphenylalanine 
(DOPA), methyldihydroxyphenylalanine (MDOPA) and 
hydrazinomethyldihydroxyphenylalanine (CDOPA) by using capillary electrophoresis 
with sulfobutyl ether-beta-cyclodextrin as a chiral selector, Electrophoresis 21 (2000) 
2583-2601. 
[37] P. T. T. Ha, A. van Schepdael, T. Hauta-aho, E. Roets, J. Hoogmartens, Simultaneous 
determination of dopa and carbidopa enantiomers by capillary zone electrophoresis, 
Electrophoresis 23 (2002) 3404-3409. 
[38] C. Borst, U. Holzgrabe, Enantioseparation of dopa and related compounds by 
cyclodextrin-modified microemulsion electrokinetic chromatography, J. Chromatogr. A 
1204 (2008) 191-196. 
25 
 
[39] S.H. Hung, W.S. Cheng, J.L. Huang, C.W. Wang, G.R. Her, Chiral electrokinetic 
chromatography-electrospray ionization-mass spectrometry using a double junction 
interface, Electrophoresis 33 (2012) 546-551. 
[40] X. Li, D. Xiao, X.M. Ou, C. McCullm, Y.M. Liu, A microchip electrophoresis-mass 
spectrometric platform for fast separation and identification of enantiomers employing 
the partial filling technique, J. Chromatogr. A 1318 (2013) 251-256. 
[41] B. Yuan, H. Wu, T. Sanders, C. McCullum, Y. Zheng, P.B. Tchounwou, Y.M. Liu, 
Chiral capillary electrophoresis-mass spectrometry of 3,4-dihydroxyphenylalanine: 
Evidence for its enantioselective metabolism in PC-12 nerve cells, Anal. Biochem. 416 
(2011) 191-195. 
[42] K.H. Gahm, A.M. Stalcup, Sulfated cyclodextrins for the chiral separations of 
catecholamines and related compounds in the reversed electrophoretic polarity mode, 
Chirality 8 (1996) 316-324. 
[43] C. Quang, M.G. Khaledi, Extending the scope of chiral separation of basic 
compounds by cyclodextrin-mediated capillary zone electrophoresis, J. Chromatogr. A 
692 (1995) 253-265. 
[44] C. García-Ruiz, M.L. Marina, Fast enantiomeric separation of basic drugs by 
electrokinetic chromatography. Application to the quantitation of terbutaline in a 
pharmaceutical preparation, Electrophoresis 22 (2001) 3191-3197. 
[45] C.E. Lin, H.T. Cheng, I.J. Fang, Y.C. Liu, C.M. Kuo, W.Y. Lin, C.H. Lin, Strategies 
for enantioseparations of catecholamines and structurally related compounds by capillary 
zone electrophoresis using sulfated β-cyclodextrins as chiral selectors, Electrophoresis 27 
(2006) 3443-3451. 
[46] M. Castro-Puyana, R. Drewnowska, V. Pérez-Fernández, M.A. García, A.L. Crego, 
M.L. Marina, Simultaneous separation of epinephrine and norepinephrine enantiomers by 
26 
 
EKC: Application to the analysis of pharmaceutical formulations, Electrophoresis 30 
(2009) 2947-2954. 
[47] B. Y. Huang, Y. C. Chen, G. R. Wang, C. Y. Liu, Preparation and evaluation of a 
monolithic molecularly imprinted polymer for the chiral separation of neurotransmitters 
and their analogues by capillary electrochromatography, J. Chromatogr. A, 1218 (2011) 
849–855. 
[48] K.B. Male, J.H.T. Luong, Chiral analysis of neurotransmitters using cyclodextrin-
modified capillary electrophoresis equipped with microfabricated interdigitated 
electrodes, J. Chromatogr. A 1003 (2003) 167-178. 
[49] D. Mangelings, Y. van der Heyden, Enantioselective capillary 
electrochromatography: recent developments and new trends, Electrophoresis 32 (2011) 
2583-2601. 
[50] P. Jac, G. K. E. Scriba, Recent advances in electrodriven enantioseparations, J. Sep. 
Sci. 36 (2013) 52-74. 
[51] E. Sánchez-López, C. Montealegre, A.L. Crego, M.L. Marina, Recent contributions 
of capillary electrophoresis to neuroscience, TrAC-Trend. Anal. Chem. 67 (2015) 82-99. 
[52] E. Sánchez-López, M. Castro-Puyana, M.L. Marina, A.L. Crego, Chiral separations 
by Capillary Electrophoresis, in: J. Anderson, A. Berthod, V. Pino, A.M. Stalcup (Eds.), 
Analytical Separation Science Volume 2, John Wiley & Sons, Ltd, Chichester, UK, 2015, 
pp 731-774.  
[53] G. Lambert, S. Naredi, E. Edén, B. Rydenhag, P. Friberg, Monoamine metabolism 
and sympathetic nervous activation following subarachoid haemorrhage: influence of 
gender and hydrocephalus, Brain Research Bulletin, 58 (2002) 77-82. 
27 
 
[54] A. N. Fonteh, R. J. Harrington, A. Tsai, P. Liao, M. G. Harrington, Free amino acid 
and dipeptide changes in the body fluids from Alzheimer’s disease subjects, Amino acids 
32 (2007) 213-224. 
[55] M. Moini, C.L. Schultz, H. Mahmood, CE/electrospray ionization-MS analysis of 
underivatized D/L-amino acids and several small neurotransmitters at attomole levels 
through the use of 18-crown-6-tetracarboxylic acid as a complexation 
reagent/background electrolyte, Anal. Chem. 75 (2003) 6282-6287. 
[56] E. Sánchez-López, M.L. Marina, A.L. Crego, Improving the sensitivity in chiral 
capillary electrophoresis, Electrophoresis 37 (2016) 19-34. 
[57] H. Muratsubaki, A, Yamaki, Profile of plasma amino acid level in rats exposed to 



















Figure 1. Scheme of the Phe-Tyr metabolic pathway depicting the structures of its 
constituents along with their theoretical pKa values in brackets (determined by Marvin 
software: http://www.chemaxon.com/marvin/sketch/index.php). Chiral center is denoted 
by *. 
Figure 2. Electropherograms displaying the chiral separation of the Phe-Tyr metabolic 
pathway constituents by CE-UV employing 160 mM M-β-CD or 160 mM HP-β-CD as 
chiral selector. Other experimental conditions, as in section 2.2. Peak identification: 
dopamine (DA), norepinephrine (NE), epinephrine (EP), 3,4-dihydroxyphenylalanine 
(DOPA), phenylalanine (Phe), and tyrosine (Tyr). Sample: standards in a proportion of 
1:1 (L:D-enantiomers), being L-enantiomers and DA in a concentration of 1 mM except 
L-Phe which was 5 mM. 
Figure 3. Electropherogram showing the chiral separation of the Phe-Tyr metabolic 
pathway constituents by the developed CE-UV methodology. Peak identification: 
dopamine (DA), norepinephrine (NE), epinephrine (EP), 3,4-dihydroxyphenylalanine 
(DOPA), phenylalanine (Phe), and tyrosine (Tyr). Experimental conditions, as in section 
2.2. Sample: standards in a proportion of 20:1 (L:D-enantiomers), being L-enantiomers 
and DA in a concentration of 1 mM except L-Phe which was 5 mM. 
Figure 4. Extracted Ion Electropherograms obtained by CE-ESI-MS2 for the chiral 
separation of the Phe-Tyr metabolic pathway constituents with injection time of 5 s 
(normal injection) in (A) and 250 s (injection with LVSS) in (B). Peak identification: 
dopamine (DA), norepinephrine (NE), epinephrine (EP), 3,4-dihydroxyphenylalanine 




Figure 5. Extracted Ion Electropherograms obtained by CE-ESI-MS2 for the chiral 
separation of the Phe-Tyr metabolic pathway constituents along with their MS2 spectra. 
Peak identification: dopamine (DA), norepinephrine (NE), epinephrine (EP), 3,4-
dihydroxyphenylalanine (DOPA), phenylalanine (Phe), and tyrosine (Tyr). Experimental 
conditions, as in section 2.3. Standard solutions were diluted in a 1:2 (v/v) proportion 
with acetonitrile and then the resulting mixture was diluted 1:1 (v/v) with formic acid 
0.25 M to mimic the treatment of plasma samples. Final concentration of standards: 600 
nM for L-enantiomers, including DA, and 200 nM for D-enantiomers. 
Figure 6. Extracted Ion Electropherograms obtained by CE-ESI-MS2 method of (A) a rat 
plasma sample (the inserts show the MS2 spectra of L-Phe and L-Tyr peaks), and (B) a 
spiked rat plasma sample (spiked with 200 nM of D-NE, D-EP, D-DOPA, D-Phe and D-
Tyr and 600 nM of DA, L-NE, L-EP, and L-DOPA). IS stands for the internal standard 


























































DA 154.0 [DA+H]+ 137.0 50 0.10 
D/L-NE 152.0 [NE-H2O+H]+ 134.9 60 0.20 
D/L-EP 184.0 [EP+H]+ 165.9 100 0.15 
D/L-DOPA 198.0 [DOPA+H]+ 151.9 / 180.8 47 0.10 
D/L-Phe 165.9 [Phe+H]+ 120.0 60 0.12 
D/L-Tyr 181.9 [Tyr+H]+ 135.9 / 164.9 42 0.09 
 
Parameters common for all studied compounds 
Fragmentation time 80 ms 
Scan mode Enhanced resolution 
Maximum accumulation time 200 ms 
Average number of scans 1 















Table 2. Analytical characteristics of the developed CE-ESI-MS2 methodology. 
 
 DA L-NE L-EP L-DOPA L-Phe L-Tyr 
Internal standard method a)       
Intercept ± t x sintercept (6 ± 50)·10-3 (10 ± 75)·10-3 (9 ± 58)·10-3 (7 ± 61)·10-3 (15 ± 100)·10-3 (7 ± 74)·10-3 
Slope ± t x sslope 1.0 ± 0.2 1.0 ± 0.2 1.3 ± 0.2 1.7 ± 0.2 1.8 ± 0.3 1.3 ± 0.2 
R2 (%) 99.4 99.6 99.5 99.6 99.2 99.2 
       
Standard addition method b)       
Slope ± t x sslope 1.03 ± 0.03 0.95 ± 0.02 1.4 ± 0.2 1.65 ± 0.09 1.7 ± 0.2 1.3 ± 0.1 
R2 (%) 99.96 99.994 99.1 99.8 99.7 99.7 
       
Accuracy       
Recovery c)  89 ± 9 % 95 ± 12 % 90 ± 9 % 87 ± 9 % 105 ± 15 % 92 ± 7 % 
       
Precision 
Instrumental repeatability d) (n=6) 
      
t, RSD (%) 0.9 0.9 0.9 0.8 0.8 0.8 
Ac, RSD (%) 7.6 7.3 6.7 4.9 7.0 3.7 
 
Method repeatability e) (n=6) 
      
t,RSD (%) 1.2 1.1 1.1 1.1 0.9 1.0 
Ac, RSD (%) 10.2 8.6 13.1 12.1 9.5 3.8 
 
Intermediate precision f) (n=9) 
      
t,RSD (%) 1.8 2.0 2.2 3.3 3.0 3.2 
Ac, RSD (%) 10.8 9.2 16.9 14.7 10.5 10.1 
       
Sensitivity       
LOD g) (nM) 77 150 40 54 67 67 
LOQ h) (nM) 257 500 133 180 223 223 
a) Five standard solutions at different concentration levels (from 0.3 to 30 µM). 
b) Addition of five known (from 0 to 20 µM) amounts of standards to a rat plasma sample. 
c) Recovery (average ± standard deviation) obtained from three independent rat plasma sample solutions spiked with known 
amounts of standards (1.5 µM for DA, L-NE, L-EP and L-DOPA and 5 µM for L-Phe and L-Tyr). 
d) Six consecutive injections (n=6) of a rat plasma sample solution spiked with 1.5 µM of DA, L-NE, L-EP and L-DOPA 
and 5 µM of L-Phe and L-Tyr. 
e) Six plasma samples solutions (n=6) from a rat spiked with 1.5 µM of DA, L-NE, L-EP and L-DOPA and 5 µM of L-Phe 
and L-Tyr, injected in triplicate. 
f) Three plasma samples solutions from a rat spiked with 1.5 µM of DA, L-NE, L-EP and L-DOPA and 5 µM of L-Phe and 
L-Tyr, injected in triplicate in 3 different days (n=9). 
g) LOD obtained for a S/N=3. 
h) LOQ obtained for a S/N=10. 
 
 
